Effects of the Delta Opioid Receptor Agonist DADLE in a Novel Hypoxia-Reoxygenation Model on Human and Rat-Engineered Heart Tissue: A Pilot Study
Intermittent hypoxia and various pharmacological compounds protect the heart from ischemia reperfusion injury in experimental approaches, but the translation into clinical trials has largely failed. One reason may lie in species differences and the lack of suitable human in vitro models to test for...
Main Authors: | Sandra Funcke, Tessa R. Werner, Marc Hein, Bärbel M. Ulmer, Arne Hansen, Thomas Eschenhagen, Marc N. Hirt |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/10/9/1309 |
Similar Items
-
ISCHEMIC PRECONDITIONING AND ITS CARDIOPROTECTIVE EFFECT IN POST-INTERVENTION CARDIAC REHABILITATION PROGRAMMES FOR PATIENTS WITH CORONARY HEART DISEASE
by: E. S. Karpova, et al.
Published: (2012-08-01) -
Preconditioning Reduces QTc Value in Patients with First Non‐ST‐Segment Elevation Myocardial Infarction (NSTEMI)
by: Christodoulos E. Papadopoulos, et al.
Published: (2003-10-01) -
Late cardiac perconditioning by phenylephrine in an isolated rat heart model is mediated by mitochondrial potassium channels
by: Afshin Nazari, et al.
Published: (2019-10-01) -
Association between Ranolazine, Ischemic Preconditioning, and Cardioprotection in Patients Undergoing Scheduled Percutaneous Coronary Intervention
by: Konstantinos Kourtis, et al.
Published: (2024-01-01) -
Donor heart preconditioning during orthotopic transplantation
by: O.А. Loskutov, et al.
Published: (2023-10-01)